Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease.
Hum Vaccin Immunother
; 18(6): 2126253, 2022 Nov 30.
Article
in En
| MEDLINE
| ID: mdl-36368038
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
4_TD
Database:
MEDLINE
Main subject:
Pneumococcal Infections
/
Pneumococcal Vaccines
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Humans
/
Middle aged
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2022
Document type:
Article